PH12016500207A1 - Anti-infective compounds - Google Patents

Anti-infective compounds

Info

Publication number
PH12016500207A1
PH12016500207A1 PH12016500207A PH12016500207A PH12016500207A1 PH 12016500207 A1 PH12016500207 A1 PH 12016500207A1 PH 12016500207 A PH12016500207 A PH 12016500207A PH 12016500207 A PH12016500207 A PH 12016500207A PH 12016500207 A1 PH12016500207 A1 PH 12016500207A1
Authority
PH
Philippines
Prior art keywords
infective compounds
compounds
infective
treatment
small molecule
Prior art date
Application number
PH12016500207A
Other languages
English (en)
Inventor
Kim Jaeseung
Kang Sunhee
Seo Min Jung
Seo Mooyoung
Seo Jeongjea
Lee Sumi
Kang Juhee
Park Dongsik
Kim Ryang Yeo
Pethe Kevin
Nam Kiyean
Kim Jeongjun
Oh Soohyun
Lee Saeyeon
Ahn Jiye
Original Assignee
Qurient Co Ltd
Pasteur Institut Korea
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Qurient Co Ltd, Pasteur Institut Korea filed Critical Qurient Co Ltd
Publication of PH12016500207A1 publication Critical patent/PH12016500207A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PH12016500207A 2013-08-02 2016-01-29 Anti-infective compounds PH12016500207A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361861750P 2013-08-02 2013-08-02
PCT/EP2014/066614 WO2015014993A2 (en) 2013-08-02 2014-08-01 Anti-infective compounds

Publications (1)

Publication Number Publication Date
PH12016500207A1 true PH12016500207A1 (en) 2016-04-25

Family

ID=51260879

Family Applications (1)

Application Number Title Priority Date Filing Date
PH12016500207A PH12016500207A1 (en) 2013-08-02 2016-01-29 Anti-infective compounds

Country Status (12)

Country Link
US (1) US20160185774A1 (enExample)
EP (1) EP3027615B1 (enExample)
JP (3) JP2016525562A (enExample)
KR (1) KR102292293B1 (enExample)
CN (2) CN109575018A (enExample)
DK (1) DK3027615T3 (enExample)
ES (1) ES2883565T3 (enExample)
HU (1) HUE056198T2 (enExample)
PH (1) PH12016500207A1 (enExample)
RU (1) RU2734760C2 (enExample)
SG (1) SG11201600686QA (enExample)
WO (1) WO2015014993A2 (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017001660A1 (en) 2015-07-02 2017-01-05 Janssen Sciences Ireland Uc Antibacterial compounds
AU2016324598A1 (en) 2015-09-17 2018-03-15 Marvin J. Miller Benzyl amine-containing heterocyclic compounds and compositions useful against mycobacterial infection
JP2019518046A (ja) * 2016-06-16 2019-06-27 ヤンセン・サイエンシズ・アイルランド・アンリミテッド・カンパニー 抗菌薬としての複素環式化合物
JP2019518050A (ja) * 2016-06-16 2019-06-27 ヤンセン・サイエンシズ・アイルランド・アンリミテッド・カンパニー 抗菌薬としての複素環式化合物
WO2018158280A1 (en) 2017-03-01 2018-09-07 Janssen Sciences Ireland Uc Combination therapy
US11129816B2 (en) 2017-10-05 2021-09-28 Quretech Bio Ab Ring-fused thiazolino 2-pyridones in combination with a drug against tuberculosis
CN108101828B (zh) * 2018-01-15 2021-05-04 西华师范大学 3-吲哚基甲酰胺类化合物及其制备方法
CN108159049B (zh) * 2018-02-01 2021-01-05 中国科学院广州生物医药与健康研究院 一种吡啶类化合物的新用途
US11034669B2 (en) 2018-11-30 2021-06-15 Nuvation Bio Inc. Pyrrole and pyrazole compounds and methods of use thereof
JPWO2020203609A1 (enExample) * 2019-03-29 2020-10-08
JP2022081710A (ja) * 2019-03-29 2022-06-01 ユーティアイ リミテッド パートナーシップ 関節リウマチを治療するためのｔ型カルシウムチャネル阻害剤の使用
TWI861208B (zh) * 2019-09-10 2024-11-11 日商鹽野義製藥股份有限公司 對分枝桿菌感染有用之含苄胺的 5,6-雜芳族化合物
WO2021048342A1 (en) 2019-09-13 2021-03-18 Janssen Sciences Ireland Unlimited Company Antibacterial compounds
MX2022003814A (es) * 2019-09-30 2022-05-06 Janssen Sciences Ireland Unlimited Co Compuestos antibacterianos de 4-quinolinona.
CA3151712A1 (en) * 2019-09-30 2021-04-08 Jerome Emile Georges Guillemont Cytochrome bd inhibitors as anti-bacterial agents for the treatment of tuberculosis
KR102381397B1 (ko) * 2020-07-10 2022-03-30 경희대학교 산학협력단 신규 나프토퀴논 유도체 화합물 및 이를 포함하는 항균용 조성물
KR20230157400A (ko) 2021-03-16 2023-11-16 얀센 사이언시즈 아일랜드 언리미티드 컴퍼니 항박테리아성 화합물
CA3211592A1 (en) 2021-03-17 2022-09-22 Jerome Emile Georges Guillemont Antibacterial compounds
CN117440958A (zh) * 2021-03-17 2024-01-23 爱尔兰詹森科学公司 抗菌化合物
CN118159543A (zh) 2021-10-28 2024-06-07 爱尔兰詹森科学公司 在治疗细菌感染中使用的咪唑并吡啶酰胺和相关化合物
WO2024089170A1 (en) 2022-10-27 2024-05-02 Janssen Sciences Ireland Unlimited Company Antibacterial compounds
WO2024223859A1 (en) 2023-04-26 2024-10-31 Janssen Pharmaceutica Nv Antibacterial compounds
WO2025017047A1 (en) 2023-07-18 2025-01-23 Janssen Pharmaceutica Nv Combination products of at least three antibiotics comprising bedaquiline, pretomanid or delamanid, and a cytochrome bc1 inhibitor, and their use in the treatment of mycobacterial infections

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2906250B1 (fr) * 2006-09-22 2008-10-31 Sanofi Aventis Sa Derives de 2-aryl-6phenyl-imidazo(1,2-a) pyridines, leur preparation et leur application en therapeutique
US20100298314A1 (en) * 2006-12-20 2010-11-25 Schering Corporation Novel jnk inhibitors
WO2009140101A2 (en) * 2008-05-12 2009-11-19 Boehringer Ingelheim International Gmbh Imidazopyridine compounds useful as mmp-13 inhibitors
EP2496578A4 (en) * 2009-11-05 2013-08-21 Univ Notre Dame Du Lac IMIDAZO [1,2-A] PYRIDINE COMPOUNDS, THEIR SYNTHESIS AND METHODS OF USE THEREOF
AU2011229423B2 (en) * 2010-03-18 2015-12-10 Institut National De La Sante Et De La Recherche Medicale (Inserm) Anti-infective compounds
US9029389B2 (en) * 2011-04-21 2015-05-12 Institut Pasteur Korea Anti-inflammation compounds
CN103324035B (zh) * 2013-06-20 2015-07-01 深圳市华星光电技术有限公司 掩膜板和阵列基板的制作方法

Also Published As

Publication number Publication date
SG11201600686QA (en) 2016-02-26
RU2016107378A3 (enExample) 2018-03-29
JP2018158941A (ja) 2018-10-11
EP3027615B1 (en) 2021-07-21
RU2016107378A (ru) 2017-09-07
JP2019131606A (ja) 2019-08-08
KR20170082450A (ko) 2017-07-14
DK3027615T3 (da) 2021-10-25
WO2015014993A3 (en) 2015-04-02
JP2016525562A (ja) 2016-08-25
HUE056198T2 (hu) 2022-02-28
JP6757768B2 (ja) 2020-09-23
EP3027615A2 (en) 2016-06-08
KR102292293B1 (ko) 2021-08-23
ES2883565T3 (es) 2021-12-09
CN109575018A (zh) 2019-04-05
WO2015014993A2 (en) 2015-02-05
CN105745208A (zh) 2016-07-06
RU2734760C2 (ru) 2020-10-23
US20160185774A1 (en) 2016-06-30

Similar Documents

Publication Publication Date Title
PH12016500207A1 (en) Anti-infective compounds
PH12012501841B1 (en) Anti-infective compounds
PH12016502436A1 (en) Anti-infective compounds
ZA201708692B (en) Antibacterial compounds
PH12016501099A1 (en) Materials and methods for controlling infections
PH12016501512A1 (en) Treatment for resistant acne
PH12015502261A1 (en) Macrocyclic deaza-purinones for the treatment of viral infections
IL242770B (en) A therapeutic combination that includes oxazolidinone-quinolones for use in the treatment of bacterial infections
MX352760B (es) Metodos para tratar infecciones intrapulmonares.
MX2015009818A (es) Agonistas de receptores gamma activados por el proliferador de peroxisoma para el tratamiento de esclerosis multiple.
ZA201503474B (en) Compositions and methods for treating bacterial infections
IN2013MU03216A (enExample)
EA201590615A1 (ru) Стимулирующие лактацию композиции на основе фосфатидилсерина
MX356102B (es) Compuestos y métodos para tratar leucemia.
MX360040B (es) Nuevo agente antibacteriano derivado de florfenicol unido a sulfoximina y el uso del mismo en el tratamiento de infecciones bacterianas en ganado vacuno.
EA201690709A1 (ru) Применение одипарцила в лечении мукополисахаридоза
IN2013MU01983A (enExample)
TR201314933A2 (tr) Bakteriyel enfeksiyonların tedavisine yönelik bir kompozisyon.
AU2013900412A0 (en) Methods Of Treating Microbial Infections, Including Skin Infections
AU2013901517A0 (en) Methods of Treating Bacterial Infections
TH149195A (th) สารประกอบซึ่งต้านการติดเชื้อ
TH1401003659A (th) ไนฟูราเทลซัลฟอกไซด์สำหรับการใช้ในการรักษาการติดเชื้อแบคทีเรีย
TH1401006729A (th) (r)-ไนฟิวราเทล, การใช้ของมันสำหรับการรักษาการติดเชื้อ และการสังเคราะห์ (r) และ (s)-ไนฟิวราเทล